Therefore, we hypothesize that increased plasma sCD127 leads to enhanced bioactivity of IL-7 in PSP and, along with preserved surface CD127 expression, improves maintenance of CD4 T-cells through IL-7 homeostatic signaling. The gene discussed is IL7; the disease is supranuclear palsy, progressive, 1.